Literature DB >> 25292068

Comparison of linear accelerator and helical tomotherapy plans for glioblastoma multiforme patients.

Timur Koca1, Hamit Basaran, Duygu Sezen, Sibel Karaca, Yasemin Ors, Deniz Arslan, Aysen Aydin.   

Abstract

BACKGROUND: Despite advances in radiotherapy, overall survival of glioblastoma multiforme (GBM) patients is still poor. Moreover dosimetrical analyses with these newer treatment methods are insufficient. The current study is aimed to compare intensity modulated radiation therapy (IMRT) linear accelerator (linac) and helical tomotherapy (HT) treatment plans for patients with prognostic aggressive brain tumors.
MATERIAL AND METHODS: A total of 20 GBM patient plans were prospectively evaluated in both linac and HT planning systems. Plans are compared with respect to homogenity index, conformity index and organs at risk (OAR) sparing effects of the treatments.
RESULTS: Both treatment plans provided good results that can be applied to GBM patients but it was concluded that if the critical organs with relatively lower dose constraints are closer to the target region, HT for radiotherapeutical application could be preferred.
CONCLUSION: Tomotherapy plans were superior to linear accelerator plans from the aspect of OAR sparing with slightly broader low dose ranges over the healthy tissues. In case a clinic has both of these IMRT systems, employment of HT is recommended based on the observed results and future re-irradiation strategies must be considered.

Entities:  

Mesh:

Year:  2014        PMID: 25292068     DOI: 10.7314/apjcp.2014.15.18.7811

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.

Authors:  Kai Wang; Yinyan Wang; Xing Fan; Jiangfei Wang; Guilin Li; Jieling Ma; Jun Ma; Tao Jiang; Jianping Dai
Journal:  Neuro Oncol       Date:  2015-09-25       Impact factor: 12.300

2.  Effects of Copper Reduction on Angiogenesis-Related Factorszzm321990in Recurrent Glioblastoma Cases

Authors:  Shima Jazayeri; Alireza Feli; Mohammad Ali Bitaraf; Masoud Solaymani Dodaran; Mazdak Alikhani; Mohammad Javad Hosseinzadeh-Attar
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

3.  Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma.

Authors:  Pei Liu; Gui Liu; Guihua Wang; Weibing Zhou; Yangqing Sun; Wen Chen; Qian Zeng; Jidong Hong; Qiongxuan Xie; Ludi Ou; Rui Wei
Journal:  Biomed Res Int       Date:  2020-03-18       Impact factor: 3.411

Review 4.  Glioblastoma Treatments: An Account of Recent Industrial Developments.

Authors:  Edouard Alphandéry
Journal:  Front Pharmacol       Date:  2018-09-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.